# Colon Metastasis From Primary Lung Cancer: A Report of a Rare Case and Review of Diagnostic and Therapeutic Challenges

**Authors:** Pedro Averbach, Caroline Cirenza, Pedro Popoutchi, Marcelo Averbach

PMC · DOI: 10.7759/cureus.98650 · Cureus · 2025-12-07

## TL;DR

A rare case of colon metastasis from lung cancer is reported, emphasizing the importance of accurate diagnosis and multidisciplinary treatment.

## Contribution

Highlights a rare metastatic pattern of lung cancer to the colon and the role of targeted therapy in treatment.

## Key findings

- Colon metastasis from lung adenocarcinoma was confirmed via histopathology and immunohistochemistry.
- Successful endoscopic mucosectomy and targeted therapy with osimertinib were used for treatment.
- Multidisciplinary approaches are essential for managing rare metastatic cases.

## Abstract

This case report aims to describe the rare occurrence of colon metastasis that originated from primary lung adenocarcinoma, highlighting the diagnostic challenges, therapeutic interventions, and clinical implications. A 62-year-old woman diagnosed with a biphenotypic lung carcinoma (squamous and adenocarcinomatous components) developed gastrointestinal (GI) symptoms. Imaging and endoscopic evaluation revealed a 3 cm sessile polypoid lesion in the ascending colon. Histopathological analysis and immunohistochemical profiling confirmed the lesion as a metastatic adenocarcinoma from the primary lung cancer. The patient underwent successful endoscopic mucosectomy with clear surgical margins, followed by targeted therapy with osimertinib due to the presence of an epidermal growth factor receptor (EGFR) mutation. Thus, this case underscores the necessity of considering metastatic lung cancer in the differential diagnosis of colonic lesions, particularly in patients with a known history of lung cancer. Comprehensive histopathological and immunohistochemical analyses are crucial for accurate diagnosis. The management of such rare metastases requires a multidisciplinary approach, integrating surgical and targeted therapies to improve patient outcomes. This report adds valuable insights into the clinical presentation, diagnostic processes, and therapeutic strategies for atypical metastatic patterns in lung cancer.

## Linked entities

- **Chemicals:** osimertinib (PubChem CID 71496458)
- **Diseases:** lung adenocarcinoma (MONDO:0005061)

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}
- **Diseases:** colonic lesions (MESH:D003108), squamous and adenocarcinomatous (MESH:D002294), gastrointestinal (GI) symptoms (MESH:D012817), Lung Cancer (MESH:D008175), adenocarcinoma (MESH:D000230), Colon Metastasis (MESH:D009362), lung adenocarcinoma (MESH:D000077192)
- **Chemicals:** osimertinib (MESH:C000596361)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12774455/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12774455/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12774455/full.md

---
Source: https://tomesphere.com/paper/PMC12774455